Effects of pirenzepine, omeprazole, lansoprazole, and rabeprazole on human neutrophil functions.
Mikawa
K
K
Akamatsu
H
H
Nishina
K
K
Niwa
Y
Y
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001562:Benzimidazoles / Q000494:pharmacology*; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D064747:Lansoprazole; D009504:Neutrophils / Q000187:drug effects* / Q000502:physiology; D009853:Omeprazole / Q000031:analogs & derivatives / Q000494:pharmacology*; D010587:Phagocytosis / Q000187:drug effects; D010890:Pirenzepine / Q000494:pharmacology*; D064750:Rabeprazole; D013481:Superoxides / Q000378:metabolism
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001562:Benzimidazoles; D064747:Lansoprazole; D013481:Superoxides; D064750:Rabeprazole; D010890:Pirenzepine; D006861:Hydrogen Peroxide; D009853:Omeprazole